IL33 and Alzheimer disease: Regarding mechanistic investigations, the ‘epithelial-immune axis’ hypothesis provides an important framework for understanding this association: persistent skin barrier dysfunction in AD patients may trigger systemic immune dysregulation through the release of epithelial-derived alarmins such IL-33, ultimately leading to aberrant activation of autoimmune responses.